Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent L-type calcium channel subunit alpha-1D, also known as Cav1.3, is a pore-forming subunit of the L-type, voltage-gated calcium channel family. It mediates the entry of calcium ions into excitable cells and plays a crucial role in various physiological processes including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. Mutations or dysfunctions have been linked to disorders such as familial sinus node dysfunction and focal idiopathic epilepsy; there may also be associations with autism spectrum disorder or primary aldosteronism.
Calcium channel blockade
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent L-type calcium channel subunit alpha-1D (Cav1.3).